acutephas
time
admiss
convalescentphas
week
later
serum
sampl
npa
sampl
time
admiss
obtain
children
age
rang
month
year
median
year
acut
expiratori
wheez
children
test
npa
pcr
respiratori
virus
children
test
hbov
igm
igg
immunoblot
hbov
serum
qpcr
remain
serum
sampl
except
convalescentphas
serum
sampl
deplet
test
hbov
qpcr
specif
nucleoprotein
gene
describ
serum
sampl
test
eia
children
followup
serum
sampl
obtain
year
later
addit
serum
sampl
healthi
medic
student
collect
inform
consent
obtain
studi
review
approv
ethic
committe
turku
helsinki
univers
hospit
put
major
viru
capsid
protein
gene
nt
hbov
st
isol
genbank
access
clone
baculoviru
vector
becton
dickinson
bioscienc
franklin
lake
nj
usa
standard
procedur
confirm
sequenc
vector
transfect
insect
cell
use
fugen
transfect
reagent
roch
basel
switzerland
two
million
adher
cell
bottl
transfect
ml
insect
express
media
lonza
basel
switzerland
mixtur
plasmid
ng
linear
baculogold
dna
becton
dickinson
bioscienc
fugen
reagent
fresh
cell
infect
time
everi
third
day
use
viru
medium
collect
previou
infect
cell
harvest
day
cell
pellet
resuspend
phosphatebuff
salin
pb
ph
concentr
cellsml
proteas
inhibitor
complet
edtafre
roch
ad
cell
lyse
sonic
subsequ
centrifug
rpm
min
vlp
purifi
cscl
gradient
ultracentrifug
rpm
ultracentrifug
beckman
fullerton
ca
usa
fraction
collect
dialysi
pb
product
concentr
column
amicon
mwco
millipor
billerica
usa
express
hbov
confirm
sodium
dodecyl
gel
electrophoresi
molecular
mass
kda
electron
microscopi
spheric
symmetr
parvoviruslik
particl
nm
diamet
figur
use
antigen
vlp
biotinyl
describ
hbov
igg
eia
conduct
describ
parvoviru
except
biotinyl
vlp
use
concentr
ngwell
cutoff
valu
calcul
igg
eia
absorb
first
serum
sampl
obtain
admiss
children
igm
matern
wane
igg
hbov
show
increas
igg
hbov
followup
test
cutoff
absorb
neg
posit
igg
eia
result
mean
sd
mean
sd
respect
igm
eia
format
use
serum
sampl
dilut
pb
tween
pbst
appli
duplic
well
plate
coat
goat
antihuman
igm
cappelicn
biomed
costa
mesa
ca
usa
min
room
temperatur
rins
time
pbst
biotinyl
hbov
vlp
appli
concentr
ngwell
incub
min
bound
antigen
visual
use
horseradish
streptavidin
dako
glostrup
denmark
pbst
plu
bovin
serum
albumin
min
follow
ophenylenediamin
dihydrochlorid
dako
min
cutoff
valu
calcul
igm
eia
absorb
followup
sampl
children
igg
posit
year
earlier
cutoff
absorb
neg
posit
igm
eia
result
mean
sd
mean
sd
respect
parvoviru
serolog
analysi
conduct
use
commerci
biotrin
dublin
ireland
inhous
eia
continu
data
skew
kolmogorovsmirnov
test
analyz
use
regress
analysi
gener
linear
model
logarithm
transform
logist
regress
analysi
use
categor
data
statist
analys
conduct
use
sasstat
r
softwar
version
sa
institut
inc
cari
nc
usa
complet
set
hbov
qpcr
result
npa
serum
sampl
avail
children
tabl
among
children
show
viremia
first
serum
sampl
second
sampl
sampl
children
show
viremia
first
sampl
sampl
high
copiesml
hbovdna
load
npa
children
show
viremia
second
sampl
dnaneg
npa
find
suggest
recent
infect
hbov
dna
load
serum
sampl
rang
copiesml
copiesml
correl
npa
dna
load
fortynin
children
npa
pcr
posit
npa
serum
sampl
pcr
posit
children
neg
pcr
result
sampl
type
tabl
longterm
followup
serum
sampl
pcr
posit
sampl
child
seroneg
year
earlier
seroconvert
followup
adult
serum
sampl
hbov
pcr
neg
wheez
children
serolog
evid
past
infect
acut
primari
hbov
infect
tabl
figur
latter
group
detect
igm
either
igg
convers
diagnost
increas
total
igm
igg
constant
igg
absorb
valu
girl
year
age
show
seroconvers
convalescentphas
serum
sampl
weakli
posit
igg
igm
either
sampl
tabl
children
show
seroconvers
increas
igg
igm
posit
incid
rate
serolog
verifi
acut
primari
hbov
infect
among
wheez
children
vari
age
peak
children
year
age
tabl
preval
hbov
immun
increas
age
reach
year
age
tabl
studi
includ
children
month
age
median
month
mean
month
eight
children
igg
posit
igg
children
presum
matern
origin
one
infant
boy
serolog
verifi
acut
hbov
infect
comparison
qpcr
eia
result
children
shown
tabl
among
children
show
viremia
serodiagnosi
hbov
infect
ie
igm
increas
igg
remain
virem
children
seroposit
seroneg
seroneg
children
show
viremia
second
sampl
possibl
indic
acut
infect
npa
sampl
time
admiss
pcr
neg
among
nonvirem
children
show
nondiagnost
serolog
result
tabl
children
serodiagnosi
girl
appar
fals
seroconvers
describ
children
pcrposit
npa
posit
result
igm
constant
igg
level
suggest
subacut
infect
hbov
npa
pcrposit
children
serodiagnosi
also
virem
tabl
patient
high
load
hbov
dna
npa
hbov
serodiagnosi
compar
low
dna
load
convers
among
children
without
hbov
dna
npa
serodiagnosi
also
virem
among
children
hbov
pcr
posit
npa
serum
sampl
serodiagnosi
remain
child
girl
month
age
seroneg
virem
second
sampl
indic
acut
infect
contrast
children
hbov
pcr
neg
npa
serum
serodiagnosi
igmneg
girl
convers
children
serolog
diagnos
acut
hbov
infect
pcr
posit
npa
virem
pcr
posit
npa
serum
tabl
one
consid
posit
pcr
result
serum
standard
diagnosi
n
eia
sensit
specif
posit
predict
valu
pcr
posit
npa
serum
standard
diagnosi
n
sensit
specif
posit
predict
valu
children
test
respiratori
virus
serolog
diagnos
acut
hbov
singl
infect
virem
hbov
dna
posit
npa
high
dna
load
among
hbov
npa
pcrposit
children
coinfect
respiratori
virus
rhinoviru
enteroviru
rsv
adenoviru
influenza
viru
parainfluenza
viru
serolog
diagnos
primari
hbov
infect
high
hbov
dna
load
low
hbov
dna
load
primari
infect
among
virem
children
serolog
confirm
acut
hbov
infect
coinfect
compar
children
hbov
dna
npa
without
serodiagnosi
viremia
differ
signific
p
followup
serum
sampl
obtain
year
later
avail
children
iggneg
children
seroconvert
acut
infect
initi
iggposit
children
still
igg
posit
igm
hbov
dna
young
adult
none
igm
igg
includ
borderlin
result
none
virem
absorb
valu
shown
figur
serodiagnost
find
infect
parvoviru
igm
posit
low
epitopetyp
specif
index
observ
among
children
serodiagnosi
hbov
infect
among
children
igm
posit
parvoviru
seroneg
hbov
seroposit
hbov
children
test
virus
analyz
clinic
characterist
median
age
children
acut
hbov
infect
diagnos
serolog
analysi
pcr
serum
year
rang
year
median
age
nonexpos
seroneg
children
year
rang
year
median
age
children
hbov
immun
year
rang
year
p
clinic
data
compar
among
children
infect
hbov
n
rhinoviru
n
rsv
n
hbov
viru
n
tabl
hbov
rhinoviru
n
hbov
rsv
n
among
singl
infect
rsv
induc
wheez
earliest
life
median
year
follow
hbov
year
rhinoviru
year
p
ageadjust
comparison
singl
infect
show
longer
durat
hospit
p
longer
durat
cough
p
longer
durat
cough
admiss
p
patient
acut
hbov
infect
patient
rhinoviru
infect
howev
children
infect
rhinoviru
higher
leukocyt
count
time
admiss
p
compar
patient
infect
rsv
patient
infect
hbov
show
longer
durat
cough
admiss
p
differ
clinic
variabl
observ
rhinoviru
rsv
whether
children
singl
infect
coinfect
hbov
found
differ
children
coinfect
hbov
virus
nonrespiratori
symptom
includ
diarrhea
rare
tabl
acut
hbov
infect
found
children
bronchiol
among
children
year
age
acut
hbov
infect
detect
children
first
wheez
episod
children
first
recurr
wheez
episod
exclud
asthmat
children
defin
children
consid
initi
daili
longterm
control
therapi
accord
recent
us
guidelin
diagnosi
manag
asthma
children
hbov
rsv
singl
infect
show
similar
overal
sever
ill
median
rang
scale
wherea
acut
otiti
media
aom
frequent
among
children
rsv
singl
infect
p
tabl
hbov
infect
commonli
diagnos
pcr
respiratori
tract
sampl
serolog
studi
report
studi
address
mainli
epidemiolog
issu
howev
endo
et
al
document
seroconvers
immunofluoresc
analysi
hbov
pcrposit
patient
lindner
et
al
detect
igm
hbov
eia
patient
virem
children
studi
wheez
children
show
use
immunoblot
prokaryot
express
hbov
capsid
antigen
hbov
infect
diagnos
serolog
also
show
uniqu
region
less
immunogen
major
viru
capsid
protein
express
hbov
vlp
insect
cell
use
igm
igg
eia
superior
immunoblot
diagnost
perform
diagnos
acut
primari
hbov
infect
children
expiratori
wheez
consist
report
crossreact
human
pathogen
parvovirus
hbov
detect
preval
rate
immun
increas
age
infant
children
year
age
continu
increas
maximum
reach
children
year
age
seropreval
among
young
adult
furthermor
igg
level
adult
divers
children
figur
result
contrast
sharpli
previou
immunoblot
result
denatur
antigen
show
decreas
seroposit
among
children
year
age
differ
like
caus
timerel
conform
depend
antibodi
similar
immun
viru
hbov
seropreval
studi
similar
rate
report
valid
accuraci
result
hbov
infect
shown
pcr
npa
sampl
preval
children
month
year
age
adult
less
affect
consist
find
incid
serolog
verifi
acut
hbov
infect
studi
highest
second
year
life
median
age
children
acut
hbov
infect
year
children
infect
year
age
seroneg
children
month
age
might
protect
infect
matern
antibodi
rapidli
decreas
seropreval
rate
infant
month
age
infant
month
age
report
studi
children
month
age
includ
infant
month
age
matern
antibodi
child
age
group
acut
hbov
infect
compar
serolog
result
pcr
found
profound
differ
npa
pcr
result
serum
pcr
result
although
result
serodiagnosi
ident
result
serum
analysi
pcr
npaposit
children
npaneg
children
hbov
serodiagnosi
howev
children
high
load
hbov
dna
npa
serodiagnosi
compar
low
dna
load
find
support
view
low
hbov
dna
load
evid
acut
primari
infect
studi
consecut
npa
sampl
shown
hbov
dna
persist
nasopharynx
sever
month
also
note
children
hbov
dna
first
serum
sampl
continu
show
viremia
log
less
dna
second
serum
sampl
obtain
averag
day
later
hbov
often
persist
serum
indic
regardless
magnitud
viremia
excel
marker
acut
hbov
infect
clinic
role
codetect
hbov
virus
npa
question
easi
determin
whether
coinfect
sequenti
infect
simultan
viral
infect
serolog
analysi
precis
approach
diagnosi
hbov
infect
compar
pcrposit
result
serum
npa
diagnost
sensit
specif
antibodi
eia
high
respect
posit
predict
valu
show
use
eia
among
wheez
children
coinfect
children
hbov
npa
pcrposit
result
particularli
children
high
hbov
dna
load
acut
primari
hbov
infect
consid
diagnosi
respiratori
diseas
differ
occurr
coinfect
observ
children
serolog
confirm
diagnosi
infect
hbov
compar
children
posit
hbov
pcr
npa
sever
group
compar
clinic
featur
hbov
infect
respiratori
viru
infect
studi
diagnos
infect
hbov
base
pcr
posit
npa
show
ideal
marker
detect
acut
hbov
infect
assess
clinic
find
patient
serolog
verifi
acut
hbov
infect
comparison
hbovinduc
wheez
induc
rhinoviru
notabl
rhinoviru
commonli
associ
wheez
older
children
recogn
risk
factor
recurr
wheez
asthma
young
children
also
notabl
comparison
hbov
rsv
rsv
domin
caus
bronchiol
infant
data
show
wheez
induc
rsv
occur
youngest
age
median
month
follow
induc
hbov
month
rhinoviru
month
ageadjust
comparison
show
hbovinfect
children
hospit
longer
rhinovirusinfect
children
ill
hbov
infect
last
longer
ill
rhinoviru
infect
howev
demonstr
coinfect
hbov
would
increas
ill
durat
sever
report
rhinoviru
rsvinduc
bronchiol
children
hbov
coinfect
seem
aom
singl
hbov
infect
differ
could
explain
inclus
rsvposit
children
group
highest
rate
aom
children
rsvinduc
wheez
alper
et
al
report
differ
frequenc
variou
respiratori
virus
associ
aom
hbov
includ
statist
signific
achiev
found
differ
frequenc
aom
children
rsvinduc
wheez
hbovinduc
wheez
serolog
confirm
primari
hbov
infect
detect
symptomat
children
sign
respiratori
viru
infect
pcr
cultur
antigen
detect
serolog
analysi
demonstr
hbov
caus
acut
wheez
young
children
moreov
fact
acut
hbov
infect
detect
hospit
children
year
age
first
episod
wheez
indic
hbov
caus
agent
bronchiol
clinic
sever
compar
rsv
hbov
respiratori
infect
diagnos
moder
accuraci
qpcr
npa
howev
reliabl
method
diagnosi
acut
symptomat
hbov
infect
pcr
serum
sampl
serolog
analysi
igm
igg
